Role of Corticotropin-Releasing Factor in Drug AddictionPotential for Pharmacological Intervention

被引:0
|
作者
Marian L. Logrip
George F. Koob
Eric P. Zorrilla
机构
[1] The Scripps Research Institute,Committee on the Neurobiology of Addictive Disorders
来源
CNS Drugs | 2011年 / 25卷
关键词
CRF1 Receptor; Extended Amygdala; CRF1 Receptor Antagonist; Ventral Tegmental Area Neuronal Activity;
D O I
暂无
中图分类号
学科分类号
摘要
Drug dependence is a chronically relapsing disorder that places an enormous strain on healthcare systems. For treatments to have long-term clinical value, they must address the causes of relapse. Corticotropin-releasing factor (CRF), a neuropeptide central to the stress response, may be one key to solving the relapse cycle. CRF is hypothesized to mediate the elevated anxiety and negative emotional states experienced during the development of dependence. This review summarizes existing data on changes in the CRF system produced by drugs of abuse and the function of CRF receptors in regulating behavioural responses to drugs of abuse, with an emphasis on drug dependence. Drug-induced changes in neuronal excitability throughout the limbic system, as well as the reversal of these neuroadaptations by CRF receptor antagonists, are also addressed. CRF receptor antagonists, by reducing the motivational effects of drug withdrawal and protracted abstinence, are proposed to be novel therapeutic targets for drug abuse and addiction.
引用
收藏
页码:271 / 287
页数:16
相关论文
共 50 条
  • [21] SAFETY OF CORTICOTROPIN-RELEASING FACTOR
    SCHULTE, HM
    CHROUSOS, GP
    CHATTERJI, DC
    GOLD, PW
    OLDFIELD, EH
    LORIAUX, DL
    LANCET, 1983, 1 (8335): : 1222 - 1222
  • [22] The role of corticotropin-releasing factor receptors in stress and anxiety
    Bale, TL
    Lee, KF
    Vale, WW
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2002, 42 (03) : 552 - 555
  • [23] CORTICOTROPIN-RELEASING FACTOR - INTRODUCTION
    VALE, W
    CIBA FOUNDATION SYMPOSIA, 1993, 172 : 1 - 4
  • [24] CORTICOTROPIN-RELEASING FACTOR AND BEHAVIOR
    KOOB, GF
    BLOOM, FE
    FEDERATION PROCEEDINGS, 1985, 44 (01) : 259 - 263
  • [25] SAFETY OF CORTICOTROPIN-RELEASING FACTOR
    HERMUS, A
    RAEMAEKERS, JMM
    PETERS, GFFM
    BARTELINK, AKM
    SMALS, AGH
    KLOPPENBORG, PWC
    LANCET, 1983, 2 (8341): : 112 - 112
  • [26] The role of corticotropin-releasing factor (CRF) in stress-induced relapse to drug seeking
    Shaham, Y
    Erb, S
    Le, AD
    Stewart, J
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 100 - 100
  • [27] Stress and Drug Addiction. "A Focus on Corticotropin-Releasing Factor"
    Varghese, Sajoy P.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 260S - 260S
  • [28] HUMAN PLACENTAL CORTICOTROPIN-RELEASING FACTOR IS SIMILAR OR IDENTICAL TO HUMAN AND RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR
    SASAKI, A
    LIOTTA, AS
    KRIEGER, DT
    CLINICAL RESEARCH, 1984, 32 (02): : A487 - A487
  • [29] HYPOPHYSECTOMY AND IMMUNE FUNCTION - ROLE OF CORTICOTROPIN-RELEASING FACTOR (CRF)
    JAIN, R
    AUDHYA, T
    HUTCHINSON, B
    HOLLANDER, CS
    CLINICAL RESEARCH, 1989, 37 (02): : A597 - A597
  • [30] CARDIOVASCULAR ACTIVATION BY SEROTONERGIC STIMULATION - ROLE OF CORTICOTROPIN-RELEASING FACTOR
    DEDEOGLU, A
    FISHER, LA
    AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03): : R859 - R864